A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia, and Select Solid Tumors and Varying Degrees of Liver Dysfunction

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01638533

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:26:52.717194+00:00

Published At

2025-02-07T00:00:00+00:00

Record Updated At

2025-02-07

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Glioma", "Hematopoietic and Lymphoid Cell Neoplasm", "Lymphoma", "Metastatic Malignant Solid Neoplasm", "Neuroendocrine Neoplasm", "Recurrent Adult Soft Tissue Sarcoma", "Recurrent Bladder Carcinoma", "Recurrent Breast Carcinoma", "Recurrent Chronic Lymphocytic Leukemia", "Recurrent Colorectal Carcinoma", "Recurrent Head and Neck Carcinoma", "Recurrent Lung Carcinoma", "Recurrent Malignant Solid Neoplasm", "Recurrent Melanoma", "Recurrent Pancreatic Carcinoma", "Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma", "Recurrent Prostate Carcinoma", "Recurrent Renal Cell Carcinoma", "Recurrent Thyroid Gland Carcinoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma", "Stage III Breast Cancer AJCC v7", "Stage III Colorectal Cancer AJCC v7", "Stage III Cutaneous Melanoma AJCC v7", "Stage III Lung Cancer AJCC v7", "Stage III Pancreatic Cancer AJCC v6 and v7", "Stage III Prostate Cancer AJCC v7", "Stage III Renal Cell Cancer AJCC v7", "Stage III Soft Tissue Sarcoma AJCC v7", "Stage IIIA Breast Cancer AJCC v7", "Stage IIIA Colorectal Cancer AJCC v7", "Stage IIIA Cutaneous Melanoma AJCC v7", "Stage IIIB Breast Cancer AJCC v7", "Stage IIIB Colorectal Cancer AJCC v7", "Stage IIIB Cutaneous Melanoma AJCC v7", "Stage IIIC Breast Cancer AJCC v7", "Stage IIIC Colorectal Cancer AJCC v7", "Stage IIIC Cutaneous Melanoma AJCC v7", "Stage IV Breast Cancer AJCC v6 and v7", "Stage IV Colorectal Cancer AJCC v7", "Stage IV Cutaneous Melanoma AJCC v6 and v7", "Stage IV Lung Cancer AJCC v7", "Stage IV Pancreatic Cancer AJCC v6 and v7", "Stage IV Prostate Cancer AJCC v7", "Stage IV Renal Cell Cancer AJCC v7", "Stage IV Soft Tissue Sarcoma AJCC v7", "Stage IVA Colorectal Cancer AJCC v7", "Stage IVB Colorectal Cancer AJCC v7", "Unresectable Solid Neoplasm"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2025-02-07"

protocolSection.identificationModule.nctId

"NCT01638533"

protocolSection.identificationModule.officialTitle

"A Phase 1 and Pharmacokinetic Single Agent Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia, and Select Solid Tumors and Varying Degrees of Liver Dysfunction"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Glioma (protocolSection.conditionsModule.conditions)
• Hematopoietic and Lymphoid Cell Neoplasm (protocolSection.conditionsModule.conditions)
• Lymphoma (protocolSection.conditionsModule.conditions)
• Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Neuroendocrine Neoplasm (protocolSection.conditionsModule.conditions)
• Recurrent Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
• Recurrent Bladder Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
• Recurrent Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Head and Neck Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Lung Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Recurrent Melanoma (protocolSection.conditionsModule.conditions)
• Recurrent Pancreatic Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Recurrent Prostate Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Recurrent Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)
• Refractory Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
• Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Stage III Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage III Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Renal Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIA Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIA Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIA Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIB Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIB Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIB Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIC Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIC Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IIIC Cutaneous Melanoma AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Breast Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Renal Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IVA Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IVB Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Unresectable Solid Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.